{
    "nctId": "NCT03738527",
    "briefTitle": "SEroma Reduction pOst MAstectomy \"SEROMA Study\"",
    "officialTitle": "Pilot RCT: Use of Tranexamic Acid (TXA) in Post Mastectomy Patients for Seroma and Hematoma Prevention",
    "overallStatus": "UNKNOWN",
    "conditions": "Seroma Complicating A Procedure, Hematoma Postoperative, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Recruitment rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer diagnosis\n* Age 18-80\n* Fluent in English\n* Female undergoing mastectomy with or without axillary intervention\n\nExclusion Criteria:\n\n* Immediate reconstruction\n* Pre-surgical radiation\n* Known allergy to TXA\n* Known thromboembolic disease\n* High-risk of thromboembolism and/or receiving anticoagulants\n* History of myocardial infarction (MI), transient ischemic attack or stroke within the last year\n* History of subarachnoid hemorrhage\n* Premenopausal women with irregular menstrual bleeding of unknown cause\n* Acquired disturbances of colour vision\n* Hematuria with renal cause\n* History of seizure disorder\n* Pregnant or breastfeeding",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}